Overcoming Antimicrobial Resistance of the Skin

ISBN-13: 9783030683238 / Angielski / Miękka / 2022

Opis

This book is a thorough, practical review of the challenges facing clinicians treating skin microbes and how to combat these therapeutic dilemmas. It expresses the critical public health concern of antimicrobial resistance and shows how microorganisms are developing the ability to halt the progress of antimicrobials like antibiotics, antivirals, and antifungals.

 

Chapters are grouped together in five sections for ease of use. The first three sections of the book convey foundational information on the mechanisms of antibiotics, antivirals, and antifungals resistance, as well as the  implications of lack of vaccination. The fourth section then turns to the specifics of drug resistance for protozoan and helminth infections focusing primarily on initial and subsequent resistance to treatment.  The book closes with a discussion on the potential solutions of innovative therapy including new delivery mechanisms, broad-spectrum antibiotics, phytocompounds, and biofilms. Chapters feature magnified, microscopic photos for identifying structures as they appear on the skin.

 

Part of the Updates in Clinical Dermatology series, Overcoming Antimicrobial Resistance of the Skin is an important resource relevant during the COVID-19 pandemic, and is written for all medical healthcare professionals.

Spis treści

Section 1: Emerging Bacterial Resistance to Antibiotics

Chapter 1: Mechanisms of Bacterial Resistance

Chapter 2: Emerging Bacterial Infections 

Chapter 3: Reemerging Bacterial Infections

Section 2: Emerging Resistance to Antivirals

Chapter 4: Mechanisms of  Non-retroviral Resistance 

Chapter 5: Mechanisms of  Retroviral Resistance

        Chapter 6: Emerging Viral Infections 

Chapter 7: Reemerging Viral Infections: Implications of Lack of Vaccination 

Section 3: Emerging Resistance to Antifungals

Chapter 8: Mechanisms of  Antifungal Resistance

Chapter 9: Emerging and Reemerging Fungal Infections

Section 4: Emerging Resistance to Drugs for Protozoan and Helminth Infections

        Chapter 10: Mechanisms of Anti-Protozoan/Helminth Drug Resistance

        Chapter 11: Emerging and Reemerging Protozoan/Helminth Infections

Section 5: Innovative Therapies on the Forefront

Chapter 12: Phage Therapy

Chapter 13: The Role of  Biofilms 

        Chapter 14: New Classes of Broad-spectrum Antimicrobials

Chapter 15: Phytocompounds

        Chapter 16: Summary

O autorze

Stephen K. Tyring, MD, PhD

University of Texas Health Science Center

Center for Clinical Studies

Houston, TX

USA

 

Stephen Andrew Moore

Arlington Center for Dermatology

Arlington Research Center

Arlington, TX

USA

 

Angela Yen Moore, MD

Arlington Center for Dermatology

Arlington Research Center

Arlington, TX

USA

 

Omar Lupi, MD, MSc, PhD

Universidade Federal do Estado do Rio de Janeiro (UNIRIO)

Policlinica Geral do Rio de Janeiro (PGRJ)

Ibero Latin American College of Dermatology (CILAD) International League of Dermatological Societies (ILDS)

Brazil